162 related articles for article (PubMed ID: 12130671)
1. The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms.
Bertolesi GE; Shi C; Elbaum L; Jollimore C; Rozenberg G; Barnes S; Kelly ME
Mol Pharmacol; 2002 Aug; 62(2):210-9. PubMed ID: 12130671
[TBL] [Abstract][Full Text] [Related]
2. Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats.
Bancila M; Copin JC; Daali Y; Schatlo B; Gasche Y; Bijlenga P
Fundam Clin Pharmacol; 2011 Aug; 25(4):469-78. PubMed ID: 21039820
[TBL] [Abstract][Full Text] [Related]
3. T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines.
Huang W; Lu C; Wu Y; Ouyang S; Chen Y
J Exp Clin Cancer Res; 2015 May; 34(1):54. PubMed ID: 25989794
[TBL] [Abstract][Full Text] [Related]
4. Low-voltage-activated calcium channels are not involved in capacitation and biological response to progesterone in human sperm.
Bonaccorsi L; Forti G; Baldi E
Int J Androl; 2001 Dec; 24(6):341-51. PubMed ID: 11737415
[TBL] [Abstract][Full Text] [Related]
5. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
Feng MG; Li M; Navar LG
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F331-7. PubMed ID: 14583435
[TBL] [Abstract][Full Text] [Related]
6. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
[TBL] [Abstract][Full Text] [Related]
7. [Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells].
Bao XX; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):212-7. PubMed ID: 22781074
[TBL] [Abstract][Full Text] [Related]
8. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
9. T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
Dziegielewska B; Casarez EV; Yang WZ; Gray LS; Dziegielewski J; Slack-Davis JK
Mol Cancer Ther; 2016 Mar; 15(3):460-70. PubMed ID: 26832797
[TBL] [Abstract][Full Text] [Related]
10. Mibefradil block of cloned T-type calcium channels.
Martin RL; Lee JH; Cribbs LL; Perez-Reyes E; Hanck DA
J Pharmacol Exp Ther; 2000 Oct; 295(1):302-8. PubMed ID: 10991994
[TBL] [Abstract][Full Text] [Related]
11. Depolarization-induced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels.
Jensen LJ; Salomonsson M; Jensen BL; Holstein-Rathlou NH
Br J Pharmacol; 2004 Jun; 142(4):709-18. PubMed ID: 15172957
[TBL] [Abstract][Full Text] [Related]
12. Progesterone-mediated calcium influx and acrosome reaction of human spermatozoa: pharmacological investigation of T-type calcium channels.
Garcia MA; Meizel S
Biol Reprod; 1999 Jan; 60(1):102-9. PubMed ID: 9858492
[TBL] [Abstract][Full Text] [Related]
13. Effect of mibefradil on sodium and calcium currents.
Strege PR; Bernard CE; Ou Y; Gibbons SJ; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G249-53. PubMed ID: 15790762
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of a recombinant low voltage-activated Ca(2+) channel by SB-209712.
McNaughton NC; Warre R; Cooper DG; Nasir S; Ranson JL; Randall A
Eur J Pharmacol; 2000 Oct; 407(1-2):53-60. PubMed ID: 11050290
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by the calcium antagonist mibefradil correlates with depolarization of the membrane potential and decreased integrin expression in human lens epithelial cells.
Nebe B; Kunz F; Peters A; Rychly J; Noack T; Beck R
Graefes Arch Clin Exp Ophthalmol; 2004 Jul; 242(7):597-604. PubMed ID: 15069564
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.
Rossier MF; Ertel EA; Vallotton MB; Capponi AM
J Pharmacol Exp Ther; 1998 Dec; 287(3):824-31. PubMed ID: 9864260
[TBL] [Abstract][Full Text] [Related]
17. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil.
Bui PH; Quesada A; Handforth A; Hankinson O
Drug Metab Dispos; 2008 Jul; 36(7):1291-9. PubMed ID: 18411403
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of T-type and L-type Ca(2+)-antagonists against noradrenaline-induced contractions of human vas deferens.
Amobi N; Guillebaud J; Smith CH
BJU Int; 2010 Aug; 106(4):578-85. PubMed ID: 20002677
[TBL] [Abstract][Full Text] [Related]
19. Influence of T-type Ca2+ (mibefradil) and Cl- (indanyloxyacetic acid 94) channel antagonists on alpha1-adrenoceptor mediated contractions in rat aorta.
Duggan JA; Tabrizchi R
Can J Physiol Pharmacol; 2000 Sep; 78(9):714-20. PubMed ID: 11007534
[TBL] [Abstract][Full Text] [Related]
20. T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiation.
Hirooka K; Bertolesi GE; Kelly ME; Denovan-Wright EM; Sun X; Hamid J; Zamponi GW; Juhasz AE; Haynes LW; Barnes S
J Neurophysiol; 2002 Jul; 88(1):196-205. PubMed ID: 12091545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
